相关实验视频
Updated: Jul 21, 2025

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
80.8K
在没有诊断能力的情况下推出新的抗结核药物
Tara Ness1,2, Le Hong Van3,2, Ilze Petermane4
1Baylor College of Medicine, Department of Pediatrics, Global TB Program, Houston, TX, USA.
Breathe (Sheffield, England)
|July 26, 2023
概括
结核病 (TB) 仍然是一个全球卫生危机. 对多药耐药结核病的新药疗法是有希望的,但需要强大的诊断来防止进一步的耐药性,并确保全球有效的治疗.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 结核病 (TB) 在2021年造成超过160万例死亡,全球新发病人数为1060万.
- 多抗药结核病 (MDR-TB),耐异酸和利芬素,占新的 (3.9%) 和先前治疗 (18%) 病例的显著比例.
- 新兴药物方案为耐药结核病提供了改进的治疗方法.
研究的目的:
- 突出新结核病药物治疗方案的开发与药物耐药性诊断工具的可用性之间的关键差距.
- 强调在没有足够的诊断能力的情况下实施新疗法的风险.
- 倡导同时推出诊断和新的结核病药物.
主要方法:
- 本研究是对结核病治疗和诊断当前趋势的审查和分析.
- 它综合了结核病发病率,死亡率和耐药性模式的数据.
- 它评估了诊断局限性对治疗疗效和耐药性发展的影响.
主要成果:
- 在* Mycobacterium tuberculosis*中识别耐药性的诊断能力远远落后于新药疗法方面的进展.
- 在没有适当的诊断的情况下实施新的结核病药物可能会加速进一步发展耐药性,减少治疗选择.
- 目前的差异可能会破坏新型治疗策略的长期有效性.
结论:
- 全球成功控制结核病取决于同步实施新的药物治疗方案和先进的诊断工具.
- 配对推广确保了资源的合理使用,并最大限度地提高了新的结核病治疗方法的死亡率.
- 综合诊断对于保持新的结核病药物的疗效和改善全球患者的治疗结果至关重要.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
201
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201
Pulmonary Tuberculosis IV
165
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
165
Pulmonary Tuberculosis I
269
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
269
Pulmonary Tuberculosis II
265
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
265
Pulmonary Tuberculosis III
365
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
365

